Contemporary Media Society in the Age of Hyperreality

This paper will examine Jean Baudrillard’s reflections regarding the contemporary relation of the public with a society that has been seemingly dominated by the hyperrealized function of the media. For Baudrillard, contemporary society’s engagement with truth as it relates to the everyday issues of life is structured, and to a certain extent, manipulated by the hyperrealized media. The masses, however, Baudrillard observes, are far from being simply exploited and controlled by media and may have in fact “adapted” to the systemic indifference of the hyperreal

Releasement and Seduction: Heidegger and Baudrillard on the Preservation of Illusion in the Epoch of Obscenity

This work interfaces the philosophies of Jean Baudrillard and Martin Heidegger. It hopes to contribute to both Heideggerian and Baudrillardian scholarship by employing Baudrillardian ideas in more effectively describing the historical happening of the so-called withdrawal of Being from man, which preoccupied much of Heidegger’s body of work. The work argues that by re-visiting an earlier idea of Baudrillard, which he termed as seduction, one finds a possible way of navigating the obscenity of the current epoch of Being. Akin to Heidegger’s idea of Gelassenheit or releasement, Baudrillard’s concept of seduction invites one to allow the real to once again appear, no longer by way of subjective representation, but to let it appear in its very disappearance in hyperreality

Tragedy, History, and Ecstasy: Concerning Nietzsche’s “Untimely” Ideas on Authentic Selfhood

This paper proposes that there exists a specific philosophical connection between Nietzsche’s thoughts on tragedy in Birth of Tragedy and his thoughts on history in “On the Uses and Disadvantages of History for Life.” The paper hopes to enrich one’s appreciation of Nietzsche’s early ideas on authentic selfhood by showing the relation between Dionysiac ecstasy and unhistorical consciousness. A postscript in the last part of the paper examines Philippine folk religiosity within the framework of the aforementioned connection between Dionysiac ecstasy and unhistorical consciousness

Selfhood and Destiny: On Heidegger’s Call for Poetic Self-Renewal in the Contemporary Age of Devastation

This essay aims to map out the path of devastation that has left ushomeless and, as the thinker Martin Heidegger says, frantically andthoughtlessly seeking for our identity. The first part of the paper will bean exposition on Heidegger’s ideas concerning the history of oblivionand how this may aid us to see where we have to be at present. Thesecond part will use for its point of departure Heidegger’s insights onforgetfulness to explain how he perceives the possibility of salvation fromsuch a threat by expounding on his ideas concerning the “fourfold” andits relationship with selfhood. The last part of the paper will then discusshis idea of poetic dwelling and how this is in fact the path towards anauthentic re-building of the self in the midst of Being’s withdrawal anddevastation. Given Heidegger’s contention that the destiny of the selfis tied up with the destining of Being, this paper will show that it isonly by thoroughly examining the destining of absence, oblivion andwithdrawal issued by history itself that we may build ourselves oncemore. This time, we shall do so in a more essential way, more heedful ofthe directives inscribed in our very beings as the ones tasked to recoverourselves from the mire of forgetfulness, and as mortal dwellers on theearth, under the sky, awaiting the divinities

Ferriols at Heidegger: Ang Pagbigkas sa Kasaysayan bilang Talagang Nangyayari

This essay aims to view the philosophy of Roque J. Ferriols, from a Heideggerian perspective. It argues that Ferriols’ way of philosophizing may be appreciated by illuminating it with Heidegger’s authentically historical way of philosophizing. Heidegger’s Wiederholung or creative retrieval of Ancient Greek philosophy is evident in Ferriols’ own approach in thinking meron. Both hold that genuinely historical philosophical thinking may not be reduced to a historiographical approach to philosophizing, akin to Nietzsche’s account of the antiquarian approach to history. To wit, it may be argued that Ferriols’ way of thinking is somehow similar to Heidegger’s insofar as it desires to perform its own unique way of creatively retrieving the meaning of meron from its authentically historical roots as talagang nangyayari, as thought and lived out in the Filipino context. Ferriols’ pagbigkas sa meron resonates with Heidegger’s call to retrieve the historically forgotten meaning of Sein

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Logos-Mythos-Ethos: Heidegger\u27s Dweller and Lopez\u27s Arctic Dreams

This paper tries to shed light upon Martin Heidegger\u27s thoughts concerning the crisis of homelessness which the thinker calls THE plight. Heidegger\u27s insights concerning language guide the course of the exposition. Aside from Heidegger, it examines Barry Lopez\u27s book Arctic Dreams, specifically the chapter entitled The Country of The Mind as a complementary resource for grounding the main points discussed in the paper. It is an exposition concerned with the relationship between logos, ethos, and mythos. The paper is a reflection on the relationship between these three words, which can hopefully provide a compass, resting neither simply on an axiology nor an occidental or oriental metaphysics, that may serve as a guide in gaining a renewed ethical way of being in the world. Ultimately, it shows that the questions which have been confronted by environmental ethics is essentially the question concerning our response to the primordial givenness of our place in the fourfold and our hearing of the silent voice of language

Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016 : a systematic analysis for the Global Burden of Disease Study 2016

Background Traumatic brain injury (TBI) and spinal cord injury (SCI) are increasingly recognised as global health priorities in view of the preventability of most injuries and the complex and expensive medical care they necessitate. We aimed to measure the incidence, prevalence, and years of life lived with disability (YLDs) for TBI and SCI from all causes of injury in every country, to describe how these measures have changed between 1990 and 2016, and to estimate the proportion of TBI and SCI cases caused by different types of injury. Methods We used results from the Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016 to measure the global, regional, and national burden of TBI and SCI by age and sex. We measured the incidence and prevalence of all causes of injury requiring medical care in inpatient and outpatient records, literature studies, and survey data. By use of clinical record data, we estimated the proportion of each cause of injury that required medical care that would result in TBI or SCI being considered as the nature of injury. We used literature studies to establish standardised mortality ratios and applied differential equations to convert incidence to prevalence of long-term disability. Finally, we applied GBD disability weights to calculate YLDs. We used a Bayesian meta-regression tool for epidemiological modelling, used cause-specific mortality rates for non-fatal estimation, and adjusted our results for disability experienced with comorbid conditions. We also analysed results on the basis of the Socio-demographic Index, a compound measure of income per capita, education, and fertility. Findings In 2016, there were 27.08 million (95% uncertainty interval [UI] 24.30-30.30 million) new cases of TBI and 0.93 million (0.78-1.16 million) new cases of SCI, with age-standardised incidence rates of 369 (331-412) per 100 000 population for TBI and 13 (11-16) per 100 000 for SCI. In 2016, the number of prevalent cases of TBI was 55.50 million (53.40-57.62 million) and of SCI was 27.04 million (24 .98-30 .15 million). From 1990 to 2016, the age-standardised prevalence of TBI increased by 8.4% (95% UI 7.7 to 9.2), whereas that of SCI did not change significantly (-0.2% [-2.1 to 2.7]). Age-standardised incidence rates increased by 3.6% (1.8 to 5.5) for TBI, but did not change significantly for SCI (-3.6% [-7.4 to 4.0]). TBI caused 8.1 million (95% UI 6. 0-10. 4 million) YLDs and SCI caused 9.5 million (6.7-12.4 million) YLDs in 2016, corresponding to age-standardised rates of 111 (82-141) per 100 000 for TBI and 130 (90-170) per 100 000 for SCI. Falls and road injuries were the leading causes of new cases of TBI and SCI in most regions. Interpretation TBI and SCI constitute a considerable portion of the global injury burden and are caused primarily by falls and road injuries. The increase in incidence of TBI over time might continue in view of increases in population density, population ageing, and increasing use of motor vehicles, motorcycles, and bicycles. The number of individuals living with SCI is expected to increase in view of population growth, which is concerning because of the specialised care that people with SCI can require. Our study was limited by data sparsity in some regions, and it will be important to invest greater resources in collection of data for TBI and SCI to improve the accuracy of future assessments. Copyright (C) 2018 The Author(s). Published by Elsevier Ltd.Peer reviewe

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases:subgroup analyses of the RESTART randomised, open-label trial

Background: Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy. Methods: RESTART was a prospective, randomised, open-label, blinded-endpoint, parallel-group trial at 122 hospitals in the UK that assessed whether starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. For this prespecified subgroup analysis, consultant neuroradiologists masked to treatment allocation reviewed brain CT or MRI scans performed before randomisation to confirm participant eligibility and rate features of the intracerebral haemorrhage and surrounding brain. We followed participants for primary (recurrent symptomatic intracerebral haemorrhage) and secondary (ischaemic stroke) outcomes for up to 5 years (reported elsewhere). For this report, we analysed eligible participants with intracerebral haemorrhage according to their treatment allocation in primary subgroup analyses of cerebral microbleeds on MRI and in exploratory subgroup analyses of other features on CT or MRI. The trial is registered with the ISRCTN registry, number ISRCTN71907627. Findings: Between May 22, 2013, and May 31, 2018, 537 participants were enrolled, of whom 525 (98%) had intracerebral haemorrhage: 507 (97%) were diagnosed on CT (252 assigned to start antiplatelet therapy and 255 assigned to avoid antiplatelet therapy, of whom one withdrew and was not analysed) and 254 (48%) underwent the required brain MRI protocol (122 in the start antiplatelet therapy group and 132 in the avoid antiplatelet therapy group). There were no clinically or statistically significant hazards of antiplatelet therapy on recurrent intracerebral haemorrhage in primary subgroup analyses of cerebral microbleed presence (2 or more) versus absence (0 or 1) (adjusted hazard ratio [HR] 0·30 [95% CI 0·08–1·13] vs 0·77 [0·13–4·61]; pinteraction=0·41), cerebral microbleed number 0–1 versus 2–4 versus 5 or more (HR 0·77 [0·13–4·62] vs 0·32 [0·03–3·66] vs 0·33 [0·07–1·60]; pinteraction=0·75), or cerebral microbleed strictly lobar versus other location (HR 0·52 [0·004–6·79] vs 0·37 [0·09–1·28]; pinteraction=0·85). There was no evidence of heterogeneity in the effects of antiplatelet therapy in any exploratory subgroup analyses (all pinteraction>0·05). Interpretation: Our findings exclude all but a very modest harmful effect of antiplatelet therapy on recurrent intracerebral haemorrhage in the presence of cerebral microbleeds. Further randomised trials are needed to replicate these findings and investigate them with greater precision. Funding: British Heart Foundation

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases : subgroup analyses of the RESTART randomised, open-label trial

Background: Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy. Methods: RESTART was a prospective, randomised, open-label, blinded-endpoint, parallel-group trial at 122 hospitals in the UK that assessed whether starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. For this prespecified subgroup analysis, consultant neuroradiologists masked to treatment allocation reviewed brain CT or MRI scans performed before randomisation to confirm participant eligibility and rate features of the intracerebral haemorrhage and surrounding brain. We followed participants for primary (recurrent symptomatic intracerebral haemorrhage) and secondary (ischaemic stroke) outcomes for up to 5 years (reported elsewhere). For this report, we analysed eligible participants with intracerebral haemorrhage according to their treatment allocation in primary subgroup analyses of cerebral microbleeds on MRI and in exploratory subgroup analyses of other features on CT or MRI. The trial is registered with the ISRCTN registry, number ISRCTN71907627. Findings: Between May 22, 2013, and May 31, 2018, 537 participants were enrolled, of whom 525 (98%) had intracerebral haemorrhage: 507 (97%) were diagnosed on CT (252 assigned to start antiplatelet therapy and 255 assigned to avoid antiplatelet therapy, of whom one withdrew and was not analysed) and 254 (48%) underwent the required brain MRI protocol (122 in the start antiplatelet therapy group and 132 in the avoid antiplatelet therapy group). There were no clinically or statistically significant hazards of antiplatelet therapy on recurrent intracerebral haemorrhage in primary subgroup analyses of cerebral microbleed presence (2 or more) versus absence (0 or 1) (adjusted hazard ratio [HR] 0·30 [95% CI 0·08–1·13] vs 0·77 [0·13–4·61]; pinteraction=0·41), cerebral microbleed number 0–1 versus 2–4 versus 5 or more (HR 0·77 [0·13–4·62] vs 0·32 [0·03–3·66] vs 0·33 [0·07–1·60]; pinteraction=0·75), or cerebral microbleed strictly lobar versus other location (HR 0·52 [0·004–6·79] vs 0·37 [0·09–1·28]; pinteraction=0·85). There was no evidence of heterogeneity in the effects of antiplatelet therapy in any exploratory subgroup analyses (all pinteraction>0·05). Interpretation: Our findings exclude all but a very modest harmful effect of antiplatelet therapy on recurrent intracerebral haemorrhage in the presence of cerebral microbleeds. Further randomised trials are needed to replicate these findings and investigate them with greater precision. Funding: British Heart Foundation